“…Interestingly there was a sustained rise of portal pressure after sclerotherapy, but not after band ligation. In addition, Vlachogiannakos et al [17] showed that somatostatin but not octreotide effectively prevents the post-endoscopic increase of HVPG. With the prognostic association of high HVPG with the course of bleeding (using vasoactive drugs and endoscopic therapy) and mortality, a randomized study showed that urgent TIPS in patients with HVPG >20 mmHg protected against continued or repeated bleeding and reduced mortality [15].…”